CellaVision AB (publ) (LON:0MR5)

CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of GBP 332.81 million. The enterprise value is 322.89 million.

Market Cap	332.81M
Enterprise Value	322.89M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.82M

Valuation Ratios

The trailing PE ratio is 28.68 and the forward PE ratio is 23.20.

PE Ratio	28.68
Forward PE	23.20
PS Ratio	5.77
PB Ratio	5.27
P/TBV Ratio	14.00
P/FCF Ratio	22.63
P/OCF Ratio	21.01
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.83, with an EV/FCF ratio of 21.95.

EV / Earnings	27.83
EV / Sales	5.42
EV / EBITDA	17.83
EV / EBIT	20.66
EV / FCF	21.95

Financial Position

The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.04.

Current Ratio	3.19
Quick Ratio	2.28
Debt / Equity	0.04
Debt / EBITDA	0.13
Debt / FCF	0.16
Interest Coverage	30.75

Financial Efficiency

Return on equity (ROE) is 19.35% and return on invested capital (ROIC) is 15.05%.

Return on Equity (ROE)	19.35%
Return on Assets (ROA)	12.30%
Return on Invested Capital (ROIC)	15.05%
Return on Capital Employed (ROCE)	21.45%
Revenue Per Employee	251,878
Profits Per Employee	50,673
Employee Count	219
Asset Turnover	0.75
Inventory Turnover	2.00

Taxes

In the past 12 months, CellaVision AB has paid 3.05 million in taxes.

Income Tax	3.05M
Effective Tax Rate	20.81%

Stock Price Statistics

The stock price has decreased by -34.92% in the last 52 weeks. The beta is 1.19, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	-34.92%
50-Day Moving Average	174.57
200-Day Moving Average	188.39
Relative Strength Index (RSI)	51.07
Average Volume (20 Days)	444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of GBP 57.68 million and earned 11.60 million in profits. Earnings per share was 0.49.

Revenue	57.68M
Gross Profit	39.70M
Operating Income	15.13M
Pretax Income	14.65M
Net Income	11.60M
EBITDA	16.61M
EBIT	15.13M
Earnings Per Share (EPS)	0.49

Balance Sheet

The company has 11.92 million in cash and 2.31 million in debt, giving a net cash position of 9.60 million.

Cash & Cash Equivalents	11.92M
Total Debt	2.31M
Net Cash	9.60M
Net Cash Per Share	n/a
Equity (Book Value)	63.17M
Book Value Per Share	2.65
Working Capital	21.43M

Cash Flow

In the last 12 months, operating cash flow was 15.84 million and capital expenditures -1.13 million, giving a free cash flow of 14.71 million.

Operating Cash Flow	15.84M
Capital Expenditures	-1.13M
Free Cash Flow	14.71M
FCF Per Share	n/a

Margins

Gross margin is 68.83%, with operating and profit margins of 26.24% and 20.12%.

Gross Margin	68.83%
Operating Margin	26.24%
Pretax Margin	25.40%
Profit Margin	20.12%
EBITDA Margin	28.80%
EBIT Margin	26.24%
FCF Margin	25.50%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.11%.

Dividend Per Share	0.20
Dividend Yield	0.11%
Dividend Growth (YoY)	17.77%
Years of Dividend Growth	n/a
Payout Ratio	39.44%
Buyback Yield	n/a
Shareholder Yield	0.11%
Earnings Yield	3.49%
FCF Yield	4.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7